A Study of Intravenously or Subcutaneously Administered REGN3500 in Healthy Adult Subjects
Clinical trial NCT02958436 · COMPLETED
Trial details
- NCT number
- NCT02958436
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-06-18
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.